| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-108-1-7 |
| P698 | PubMed publication ID | 2962527 |
| P50 | author | William B. Kannel | Q15439387 |
| Daniel Levy | Q88264418 | ||
| P2093 | author name string | Castelli WP | |
| Savage DD | |||
| Anderson KM | |||
| Christiansen JC | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | echocardiography | Q216933 |
| left ventricular hypertrophy | Q1628627 | ||
| P304 | page(s) | 7-13 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study | |
| P478 | volume | 108 |
| Q71710659 | 123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy |
| Q63811737 | 70-year legacy of the Framingham Heart Study |
| Q60947923 | A Fortified Method to Screen and Detect Left Ventricular Hypertrophy in Asymptomatic Hypertensive Adults: A Korean Retrospective, Cross-Sectional Study |
| Q38597918 | A Systems Biology Approach to Investigating Sex Differences in Cardiac Hypertrophy. |
| Q37384785 | A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy |
| Q77853784 | ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stab |
| Q42021700 | Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity |
| Q41259321 | Adaptive and genetic alterations of the renin angiotensin system in cardiac hypertrophy and failure |
| Q37313549 | Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress |
| Q35108036 | Adverse vascular risk is related to cognitive decline in older adults. |
| Q89495864 | Aged garlic extract reduces left ventricular myocardial mass in patients with diabetes: A prospective randomized controlled double-blind study |
| Q50999334 | Ambulatory blood pressure and echocardiographic left ventricular dimensions in elderly hypertensive subjects. |
| Q33710469 | Ambulatory blood pressure monitoring and echocardiography--noninvasive techniques for evaluation of the hypertensive patient |
| Q57489805 | Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment |
| Q53777785 | Amlodipine as an antiischemic drug is superior to long acting nitrates. |
| Q40482679 | An update on coronary risk factors |
| Q57800954 | Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes |
| Q37756022 | Anti-hypertensive drugs and left ventricular hypertrophy: a clinical update |
| Q35918824 | Antihypertensive drugs and the heart |
| Q35155221 | Aortic unfolding determined using non-contrast cardiac computed tomography: correlations with age and coronary artery calcium score |
| Q34962208 | Are all antihypertensive drug classes equal in reducing left ventricular hypertrophy? |
| Q41527587 | Assessment of antihypertensive treatment by ambulatory blood pressure |
| Q51589485 | Association between left ventricular hypertrophy and erythrocyte sodium-lithium exchange in normotensive subjects with and without NIDDM. |
| Q45108163 | Association of heart rate and left ventricular structure in a rural population in Korea |
| Q33802557 | Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham heart study |
| Q30477731 | Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension |
| Q45295030 | Association of ventricular premature complexes with electrocardiographic-estimated left ventricular mass in a population of African-American and white men and women (The Atherosclerosis Risk in Communities |
| Q36839438 | Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass |
| Q37197090 | Asymptomatic obese hypertensives and need of routine echocardiography for left ventricular mass assessment and treatment |
| Q73782365 | Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy |
| Q44140655 | Beyond blood pressure reduction in the treatment of arterial hypertension. Clinical implications of the LIFE study |
| Q43704585 | Blood pressure and left ventricular anatomy and function after heart transplantation |
| Q75220920 | Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy |
| Q74495241 | Blood pressure determinants of left ventricular wall thickness and mass index in hypertension: comparing office, ambulatory and exercise blood pressures |
| Q86678389 | Blood pressure responses to stress: Relation to left ventricular structure and function |
| Q34207941 | Caloric restriction: powerful protection for the aging heart and vasculature. |
| Q34971967 | Cardiac and vascular consequences of pre-hypertension in youth |
| Q46442339 | Cardiac contractility, central haemodynamics and blood pressure regulation during semistarvation |
| Q51998665 | Cardiac evaluation for simultaneous pancreas-kidney transplantation and incidence of cardiac perioperative complications: preliminary study. |
| Q36381499 | Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect? |
| Q30833375 | Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone |
| Q34973985 | Cardiac sequelae of hypertension |
| Q68704408 | Cardiac structure and function in continuous ambulatory peritoneal dialysis: influence of blood purification and hypercirculation |
| Q73215887 | Cardiovascular effects of recombinant human erythropoietin in predialysis patients |
| Q39552729 | Cardiovascular, hemodynamic, neuroendocrine, and inflammatory markers in women with and without vasomotor symptoms |
| Q73009139 | Carotid artery and left ventricular structural relationship in asymptomatic men at risk for cardiovascular disease |
| Q51035773 | Carotid artery measures are strongly associated with left ventricular mass in older adults (a report from the Cardiovascular Health Study). |
| Q36820296 | Cellular mechanisms of cardiac hypertrophy |
| Q33830998 | Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey |
| Q54264644 | Changes in pulmonary hemodynamics with aging in a predominantly hypertensive population |
| Q59573861 | Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease |
| Q64290185 | Clinical Characteristics Associated with Electrocardiographic Left Ventricular Hypertrophy in Clinical Normotensives without a History of Hypertension: a Cross-Sectional Study |
| Q37503009 | Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology |
| Q44875045 | Comparison of effects of exercise and diuretic on left ventricular geometry, mass, and insulin resistance in older hypertensive adults |
| Q73200747 | Comparison of left ventricular mass and function in obese versus nonobese women <40 years of age |
| Q35124089 | Comparison of radiological findings of chest x-ray with echocardiography in determination of the heart size |
| Q71126033 | Comparison of technetium-99m sestamibi-gated tomographic perfusion imaging with echocardiography and electrocardiography for determination of left ventricular mass |
| Q41580267 | Considerations for racial differences in the athlete's heart and related cardiovascular disease |
| Q51986656 | Context-dependency of the relation between left ventricular mass and AGT gene variants. |
| Q35196561 | Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction |
| Q36884188 | Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project |
| Q35316627 | Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease |
| Q33545464 | Coronary heart disease. Stable and unstable syndromes |
| Q48574034 | Correlation between silent cerebral white matter lesions and left ventricular mass and geometry in essential hypertension |
| Q43720734 | Correlation relationship assessment between left ventricular hypertrophy voltage criteria and body mass index in 41,806 Swiss conscripts. |
| Q37818475 | Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor |
| Q73028205 | Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients |
| Q64072149 | Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA |
| Q39440042 | Detection of coronary artery disease in the presence of left ventricular atrophy |
| Q42020555 | Determinants of disease and disability in the elderly: The Rotterdam elderly study |
| Q30489678 | Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study |
| Q47378647 | Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size |
| Q57264359 | Development and Validation of a Clinical Score to Identify Echocardiographic Left Ventricular Hypertrophy in Patients With Cardiovascular Disease |
| Q59573809 | Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor |
| Q35157562 | Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study |
| Q46786772 | Diastolic blood pressure reduction contributes more to the regression of left ventricular hypertrophy: a meta-analysis of randomized controlled trials |
| Q36745702 | Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure |
| Q43556606 | Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function |
| Q39861343 | Disproportionately high risk of left ventricular hypertrophy in Indo-Asian women: a call for more studies |
| Q50944369 | ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus. |
| Q38024826 | Early origins of heart disease: low birth weight and the role of the insulin-like growth factor system in cardiac hypertrophy. |
| Q57747612 | Echocardiographic Left Ventricular Hypertrophy: Clinical Characteristics. The Framingham Heart Study |
| Q67897247 | Echocardiographic assessment of doxazosin on left ventricular mass in patients with essential hypertension |
| Q30469853 | Echocardiographic left ventricular mass index predicts incident stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study |
| Q24810969 | Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? |
| Q51552708 | Effect of blood glucose on left ventricular mass in patients with hypertension and type 2 diabetes mellitus. |
| Q72189531 | Effect of blood pressure lowering on coronary vasodilator reserve in arterial hypertension |
| Q71581344 | Effect of echocardiography on clinical impact and patient outcome in hypertension |
| Q77220964 | Effect of hormone replacement therapy on left ventricular hypertrophy |
| Q34245309 | Effect of sex hormones on cardiac mass |
| Q47345449 | Effect of total adipose weight and systemic hypertension on left ventricular mass in children |
| Q33715015 | Effects of body size and body fatness on left ventricular mass in children and adolescents: Project HeartBeat! |
| Q34555164 | Effects of gender on the renin-angiotensin system, blood pressure, and renal function |
| Q47275205 | Effects of obesity and weight loss on cardiac function and valvular performance. |
| Q43134213 | Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis. |
| Q47423593 | Effects of weight loss on ventricular systolic and diastolic functions and left ventricular mass assessed by tissue doppler imaging in obese geriatric women: preliminary report |
| Q94207710 | Einthoven Dissertation Prizes 2002 |
| Q84135069 | Electrocardiographic abnormalities and home blood pressure in treated elderly hypertensive patients: Japan home versus office blood pressure measurement evaluation in the elderly (J-HOME-Elderly) study |
| Q42635680 | Electrocardiographic indices of left ventricular hypertrophy and repolarization phase share the same genetic influences: a twin study. |
| Q40806300 | Electrocardiographic left ventricular hypertrophy by five criteria among civil servants in Benin City, Nigeria: prevalence and correlates |
| Q34091890 | Epidemiological and clinical studies on insulin resistance and diabetes |
| Q51405375 | Evaluation of the hypertensive patients in southeastern Anatolia; demographic features and target organ damage. |
| Q61684218 | Evaluation of various electrocardiographic criteria for left ventricular hypertrophy in patients with stable angina pectoris: influence of using modified limb electrodes |
| Q37102739 | Factors Contributing to Development and Reversal of LVH: A Pilot Study |
| Q47995390 | Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography |
| Q77766325 | Familial predisposition of left ventricular hypertrophy |
| Q45331730 | Fragmented QRS complexes are associated with increased left ventricular mass in patients with essential hypertension. |
| Q30357928 | Genetic association of left ventricular mass assessed by M-mode and two-dimensional echocardiography. |
| Q41076787 | Genetic influence on left ventricular structure and function: a Korean twin and family study |
| Q34458072 | Genetics of the Framingham Heart Study population |
| Q38835942 | Geriatric Cardiology: An Emerging Discipline |
| Q51364038 | Ghrelin PYY 3-36 serum changes in left ventricular hypertrophic, insulin-resistant, hypertensive obese patients. |
| Q35188660 | Glycolysis and pyruvate oxidation in cardiac hypertrophy--why so unbalanced? |
| Q34362887 | Heart failure in acute ischemic stroke |
| Q36596985 | Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem? |
| Q34394483 | Helicobacter pylori infection in healthy people: a dynamic process? |
| Q37359599 | Hemodynamic and echocardiographic profiles in African American compared with White offspring of hypertensive parents: the HyperGEN study |
| Q88044960 | Higher blood pressure during light exercise is associated with increased left ventricular mass index in normotensive subjects |
| Q47775639 | Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoam |
| Q37109220 | Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications |
| Q41600669 | Hypertension and coronary artery disease |
| Q40741143 | Hypertension and left ventricular hypertrophy: is drug therapy beneficial? |
| Q41653529 | Hypertension and pathologic cardiovascular remodeling: a potential therapeutic role for T-type calcium antagonists |
| Q67903651 | Hypertension, Hypertrophy, and the Occurrence of Cardiovascular Disease |
| Q46353950 | Hypertensive cardiovascular disease in African Americans |
| Q33634050 | Impact of prehypertension on left ventricular mass and QT dispersion in adult black Nigerians |
| Q33783561 | Impact of prehypertension on left ventricular structure, function and geometry |
| Q53311454 | Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension |
| Q40893163 | Increased left ventricular cavity size, not wall thickness, potentiates myocardial ischemia |
| Q44462213 | Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death |
| Q37432845 | Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional study. |
| Q36666455 | Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow? |
| Q24806075 | Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus |
| Q44104213 | Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity |
| Q73079538 | Influence of fluid volume variations on the calculated value of the left ventricular mass measured by echocardiogram in patients submitted to hemodialysis |
| Q33721061 | Influence of sex hormones and phytoestrogens on heart disease in men and women |
| Q34513832 | Insulin resistance and cardiovascular risk in the pediatric patient |
| Q57388797 | Insulin resistance syndrome and left ventricular mass in an elderly population (The Rotterdam Study) |
| Q53338927 | Interpretation of echocardiographic measurements: a call for standardization. |
| Q33359991 | Intradialytic hypotension and cardiac remodeling: a vicious cycle |
| Q38663332 | Is hepatic steatosis associated with left ventricular mass index increase in the general population? |
| Q38546075 | Ivabradine: Current and Future Treatment of Heart Failure. |
| Q68469391 | Left Ventricular Mass in Children and Adolescents |
| Q57540337 | Left atrial volume as an index ofleft atrial size: a population-based study |
| Q71690278 | Left ventricular abnormalities in children, adolescents and young adults with renal disease |
| Q51592007 | Left ventricular contractility and insulin resistance in essential hypertension. |
| Q73480527 | Left ventricular function, cardiac dysrhythmias, atrial activation, and volumes in nondipper hypertensive individuals with left ventricular hypertrophy |
| Q35861560 | Left ventricular hypertrophy |
| Q36055146 | Left ventricular hypertrophy after hypertensive pregnancy disorders. |
| Q51940087 | Left ventricular hypertrophy and blood pressure as predictors of cognitive decline in old age. |
| Q37147735 | Left ventricular hypertrophy and clinical outcomes in hypertensive patients |
| Q47556312 | Left ventricular hypertrophy and cognitive function: a systematic review |
| Q46406543 | Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects |
| Q83365211 | Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men? |
| Q41036688 | Left ventricular hypertrophy in hypertension--general and local trends in diagnosis and therapy |
| Q50611362 | Left ventricular hypertrophy on electrocardiogram: prognostic implications from a 10-year cohort study of older subjects: a report from the Bronx Longitudinal Aging Study. |
| Q48572827 | Left ventricular hypertrophy predicts cardiovascular events in hypertensive patients with coronary artery calcifications |
| Q67882204 | Left ventricular hypertrophy regression during antihypertensive treatment |
| Q36285368 | Left ventricular hypertrophy--the problem and possible solutions. |
| Q39489037 | Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study |
| Q35876445 | Left ventricular hypertrophy. Its relationship to obesity and hypertension |
| Q40445518 | Left ventricular hypertrophy. Prevalence in older patients and management |
| Q37076003 | Left ventricular hypertrophy: Diagnosis, prognosis, and management |
| Q30867239 | Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging. |
| Q74299082 | Left ventricular hypertrophy: unresolved issues |
| Q35579634 | Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? |
| Q43545510 | Left ventricular mass and correlated atherosclerotic risk factors in young adolescents: report from Chin-Shan community cardiovascular study in Taiwan. |
| Q72382619 | Left ventricular mass and diastolic filling patterns in quadriplegia and implications for effects of normal aging on the heart |
| Q80577330 | Left ventricular mass and heart rate variability in middle-aged and elderly salt-sensitive hypertensive subjects |
| Q33565998 | Left ventricular mass estimation by echocardiography: is it clinically useful? |
| Q77104584 | Left ventricular mass index increases in proportion to the progression of diabetic nephropathy in Type 2 diabetic patients |
| Q37385696 | Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study |
| Q46634211 | Losartan controlled blood pressure and reduced left ventricular hypertrophy but did not alter arrhythmias in hypertensive men with preserved systolic function |
| Q47668907 | Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy. |
| Q35113671 | Management of Hypertension among Patients with Coronary Heart Disease |
| Q34070051 | Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients? |
| Q43998492 | Management of mild hypertension |
| Q73069764 | Marked ventricular repolarization abnormalities in highly trained athletes' electrocardiograms: clinical and prognostic implications |
| Q77291970 | Maternally transmitted susceptibility to non-insulin-dependent diabetes mellitus and left ventricular hypertrophy |
| Q30446578 | Measurement of left ventricular mass by contrast ventriculography. |
| Q51919736 | Measurement of wall thickness alone does not accurately assess the presence of left ventricular hypertrophy. |
| Q37695510 | Mechanisms underlying hemodynamic and neuroendocrine stress reactivity at different phases of the menstrual cycle |
| Q28372859 | Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy |
| Q37617434 | Mild and Short-Term Caloric Restriction Prevents Obesity-Induced Cardiomyopathy in Young Zucker Rats without Changing in Metabolites and Fatty Acids Cardiac Profile. |
| Q36013111 | Moexipril and left ventricular hypertrophy |
| Q39788142 | Myocardin-related transcription factor-A induces cardiomyocyte hypertrophy |
| Q50910087 | Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. |
| Q35052188 | New paradigms in preventive cardiology: unconventional coronary risk factors |
| Q30863321 | Nonparametric comparison of entire ROC curves for computerized ECG left ventricular hypertrophy algorithms using data from the Framingham Heart Study. |
| Q37426993 | Normal systolic blood pressure and risk of heart failure in US male physicians |
| Q51960702 | Normal values of pulmonary capillary wedge pressure and the blood pressure response to the Valsalva manoeuvre in healthy elderly subjects. |
| Q38733484 | Normative Left Ventricular M-Mode Echocardiographic Values in Preterm Infants up to 2 kg. |
| Q36504986 | Obesity and the heart: cardiovascular magnetic resonance imaging evidence of the beneficial effects of bariatric surgery |
| Q43926526 | Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy |
| Q40356250 | Onset and Regression of Pregnancy-Induced Cardiac Alterations in Gestationally Hypertensive Mice: The Role of the Natriuretic Peptide System |
| Q71324601 | Outcome and risk factors of ischemic heart disease in chronic uremia |
| Q69298128 | Pathogenesis of heart failure |
| Q41733651 | Pathological versus physiological left ventricular hypertrophy: a review |
| Q36995248 | Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies |
| Q36972415 | Pharmacological Strategies to Retard Cardiovascular Aging |
| Q57154485 | Prediction of Mortality Risk by Different Methods of Indexation for Left Ventricular Mass |
| Q38875978 | Predictive Performance of Echocardiographic Parameters for Cardiovascular Events Among Elderly Treated Hypertensive Patients. |
| Q34316673 | Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients |
| Q41819172 | Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice. |
| Q37799428 | Prevention, Diagnosis, and Treatment of Hypertensive Heart Disease |
| Q51271600 | Prognostic value of Doppler echocardiographic-derived coronary flow velocity reserve of left anterior descending artery in octogenarians with stress echocardiography negative for wall motion criteria. |
| Q45261291 | Quality of life, dyspnea and ventricular function in patients with hypertension. |
| Q36716618 | Regression of Increased Left Ventricular Mass by Antihypertensives |
| Q35170122 | Regression of left ventricular hypertrophy is a key goal of hypertension management |
| Q35209074 | Regression of left ventricular hypertrophy: are there preferred drugs? |
| Q35909120 | Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile |
| Q41265199 | Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults |
| Q48401298 | Relation of left ventricular hypertrophy to regional cerebral blood flow: single photon emission computed tomography abnormalities in essential hypertension |
| Q59279858 | Relation of leisure-time physical activity to structural and functional arterial properties of the common carotid artery in male subjects |
| Q49051725 | Relationship between left ventricular mass and blood pressure in treated hypertension |
| Q44331770 | Relationship between plasma insulin and left ventricular mass in normotensive participants of the Gubbio Study. |
| Q44278786 | Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin |
| Q47981829 | Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction |
| Q67902680 | Renin–Sodium Profile and the Risk of Myocardial Infarction in Patients with Hypertension |
| Q37040166 | Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension? |
| Q67897810 | Reversal of cardiac and vascular hypertrophy by antihypertensive therapy |
| Q36683703 | Reversibility of myocardial dyskinaesia due to severe hypertension |
| Q40977152 | Risk and management of hypertension-related left ventricular hypertrophy |
| Q34182981 | Role of echocardiography in primary care medicine. Controversies in hypertension, atrial fibrillation, stroke, and endocarditis |
| Q37091119 | Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease |
| Q34383040 | Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy |
| Q34069733 | Secular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study |
| Q44415952 | Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: The framingham heart study |
| Q44040191 | Serum cholesterol affects blood pressure regulation |
| Q36310906 | Sex, haemoglobin and kidney disease: new perspectives |
| Q37387789 | Shorter height is related to lower cardiovascular disease risk - a narrative review |
| Q40582358 | Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality |
| Q38262422 | Structural and Metabolic Effects of Obesity on the Myocardium and the Aorta |
| Q34387677 | Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease |
| Q73383911 | Synergistic effect of angiotensin-converting enzyme and angiotensinogen gene on cardiac hypertrophy |
| Q36904769 | Telomere dynamics during aging in polygenic left ventricular hypertrophy. |
| Q46886901 | Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension |
| Q34188516 | The DD-ACE genotype and cardiovascular disease. |
| Q28397317 | The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms |
| Q45278845 | The associations of body size and body composition with left ventricular mass: impacts for indexation in adults |
| Q44354158 | The determinants of left ventricular hypertrophy defined by Sokolow-Lyon criteria in untreated hypertensive patients |
| Q37514842 | The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation |
| Q81045476 | The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus |
| Q41632415 | The heart and conduit vessels in hypertension |
| Q35128460 | The impact of left ventricular hypertrophy on survival in candidates for liver transplantation |
| Q30476766 | The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q34278791 | The importance of age and obesity on the relation between diabetes and left ventricular mass |
| Q36006533 | The intersection between aging and cardiovascular disease |
| Q34179251 | The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern |
| Q33741450 | The older man's heart and heart disease |
| Q94554940 | The polygenic architecture of left ventricular mass mirrors the clinical epidemiology |
| Q37146091 | The prognostic value of the ECG in hypertension: where are we now? |
| Q36421051 | The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension |
| Q33563082 | Transthoracic echocardiography for evaluation of hypertensive heart disease |
| Q40199205 | Use of predictive markers to improve cardiovascular protection |
| Q50954064 | Validity of electrocardiographic estimates of left ventricular hypertrophy and mass in African Americans (The Charleston Heart Study). |
| Q38695193 | Value of echocardiographic and ambulatory blood pressure monitoring in hypertension |
| Q46896470 | Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth. |
| Q40411184 | Ventricular tachyarrhythmias, myocardial ischemia, and sudden cardiac death in patients with hypertensive heart disease |
| Q47338193 | Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects |
| Q35562738 | Which measures of adiposity predict subsequent left ventricular geometry? Evidence from the Bogalusa Heart Study |
| Q95466251 | [Arterial hypertension in patients with coronary artery disease] |
| Q79713790 | [Standard-ECG] |
Search more.